Abstract
Matrix metalloproteinases (MMPs) have been implicated in both normal and pathologic processes. In cancer in particular, in vitro and animal studies showed an involvement of MMPs in many stages of cancer progression. This led to the development of MMP inhibitors that in most cases failed in clinical trials. In this review we go over the role of MMPs in the different stages of cancer progression and try to understand why the early generation of MMP inhibitors failed. The analysis of the lessons from this first experience, plus the review of the current knowledge that shows that MMPs may be pro-or anti-tumorigenic may set the stage for a future success for this therapeutic strategy in cancer.
Keywords: Cancer, clinical trials, matrix metalloproteinases, MMP inhibitors, therapy, therapeutic strategy, anti-tumorigenic, Malignant tumors, bind amino acid, glycosylphosphatidylinositol anchor, vascular and inflammatory cells, plasminogen-null mice, intramolecular autolytic, plasminogen-activating enzyme, Plasmin
Current Pharmaceutical Biotechnology
Title: Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances
Volume: 12 Issue: 11
Author(s): D. Raffo, O. Pontiggia and M. Simian
Affiliation:
Keywords: Cancer, clinical trials, matrix metalloproteinases, MMP inhibitors, therapy, therapeutic strategy, anti-tumorigenic, Malignant tumors, bind amino acid, glycosylphosphatidylinositol anchor, vascular and inflammatory cells, plasminogen-null mice, intramolecular autolytic, plasminogen-activating enzyme, Plasmin
Abstract: Matrix metalloproteinases (MMPs) have been implicated in both normal and pathologic processes. In cancer in particular, in vitro and animal studies showed an involvement of MMPs in many stages of cancer progression. This led to the development of MMP inhibitors that in most cases failed in clinical trials. In this review we go over the role of MMPs in the different stages of cancer progression and try to understand why the early generation of MMP inhibitors failed. The analysis of the lessons from this first experience, plus the review of the current knowledge that shows that MMPs may be pro-or anti-tumorigenic may set the stage for a future success for this therapeutic strategy in cancer.
Export Options
About this article
Cite this article as:
Raffo D., Pontiggia O. and Simian M., Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances, Current Pharmaceutical Biotechnology 2011; 12 (11) . https://dx.doi.org/10.2174/138920111798377085
DOI https://dx.doi.org/10.2174/138920111798377085 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endothelial Remodelling and Intracellular Calcium Machinery
Current Molecular Medicine Selectins as Targets in Inflammatory Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Delayed Multiple Non-ischemic Cerebral Enhanced Lesions After Endovascular Therapy For Left Internal Carotid Aneurysm: A Case Report
Current Medical Imaging Dye Visualization - A Method for Investigating Biomechanical Flows
Current Pharmaceutical Biotechnology New Designer Drugs (Synthetic Cannabinoids and Synthetic Cathinones): Review of Literature
Current Pharmaceutical Design The Roles of MicroRNAs in Atherosclerosis
Current Medicinal Chemistry Role of AGEs-RAGE System in Cardiovascular Disease
Current Pharmaceutical Design Chymase Inhibitors
Current Pharmaceutical Design Multifaceted Individualities in Pharmacological Treatments of Obesity
Current Clinical Pharmacology Pathophysiology of IgG4-Related Disease
Current Immunology Reviews (Discontinued) Use of Telemetry Blood Pressure Transmitters to Measure Intracranial Pressure (ICP) in Freely Moving Rats
Current Neurovascular Research Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges
Current Vascular Pharmacology Pathophysiology of Cardiovascular Diseases and the Role of Vitamins, and Herbal Extracts in the Reduction of Cardiovascular Risks
Cardiovascular & Hematological Agents in Medicinal Chemistry New Devices for Treating Acute Ischemic Stroke
Recent Patents on CNS Drug Discovery (Discontinued) Papillary Tumor of the Pineal Region with Parinaud Syndrome: A Case Report
Current Medical Imaging Physical Function and Exercise in Older Patients with Cardiovascular and Respiratory Conditions
Current Pharmaceutical Design Editorial: Neuronanomedicine - (Part II)
Current Medicinal Chemistry Preface
Current Medical Imaging The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies
Current Neuropharmacology Chemokines in Cardiovascular Remodeling: Clinical and Therapeutic Implications
Current Molecular Medicine